Showing 701 - 720 results of 1,261 for search 'Neymar~', query time: 3.02s Refine Results
  1. 701
  2. 702
  3. 703
  4. 704
  5. 705
  6. 706

    Clinical Biochemistry ; fundamentals of biomedical science /

    Published 2017
    Table of Contents: “…Biochemical investigations and quality control / David Cameron -- Automation / Tim James -- Kidney disease / Edmund Lamb -- Hyperuricaemia and gout / Joanne Marsden -- Fluid and electrolyte disorders / Tim James -- Acid-base disorders / David Tierney -- Clinical enzymology and biomarkers / Paul Collinson, Amy Lloyd -- Liver function tests / Roy Sherwood -- Abnormalities of lipid metabolism / Mike France -- Disorders of calcium, phosphate, and magnesium homeostasis / Nessar Ahmed -- Abnormal pituitary function ; Thyroid disease / Garry McDowell -- Diabetes mellitus and hypoglycaemia / Allen Yates, Ian Laing -- Adrenal disease / John Honour -- Reproductive endocrinology / Ian Laing, Julie Thornton -- Biochemical nutrition / Pat Twomey, William Simpson -- Gastrointestinal disorders and malabsorption / Garry McDowell, Gordon Brydon -- Specific protein markers / Gerald Maguire -- Cancer biochemistry and tumour markers / Joanne Adaway, Gilbert Wieringa -- Inherited metabolic disorders and newborn screening / Mary Anne Preece -- Therapeutic drug monitoring / Robin Whelpton, Nigel Brown, Robert Flanagan -- Chemical toxicology / Gwendolen Ayers.…”
    View in OPAC
    Book
  7. 707
  8. 708
  9. 709
  10. 710
  11. 711
  12. 712
  13. 713
  14. 714
  15. 715
  16. 716
  17. 717
  18. 718
  19. 719

    Case report: Near-complete response to neratinib-based treatment in HR-positive HER2-amplified metastatic breast cancer refractory to trastuzumab deruxtecan by Ünal Metin Tokat, Ashkan Adibi, Ashkan Adibi, Esranur Aydın, Şevval Nur Bilgiç, Eylül Özgü, Onur Tutar, Mutlu Demiray

    Published 2025-01-01
    “…Although this regimen exhibits high rates of response and disease control in both HR+ and HR− cohorts, some patients could have intrinsic or develop acquired resistance to trastuzumab and/or pertuzumab. Here, we achieved a near-complete response in HR+ HER2-amplified and overexpressing metastatic BC twice through molecular tumor board (MTB) discussions: initially, with trastuzumab deruxtecan (T-DXd) when HER2 IHC was positive, and, then, with neratinib plus fulvestrant plus paclitaxel when IHC was negative. …”
    Get full text
    Article
  20. 720

    Viscosity Measurements of Dilute Poly(2-ethyl-2-oxazoline) Aqueous Solutions Near Theta Temperature Analyzed within the Joint Rouse-Zimm Model by Jana Tóthová, Katarína Paulovičová, Vladimír Lisý

    Published 2015-01-01
    “…The steady-state shear viscosity of low-concentrated Poly(2-ethyl-2-oxazoline) (PEOX) aqueous solutions is measured near the presumed theta temperature using the falling ball viscometry technique. …”
    Get full text
    Article